Medicare Enrollees With Cancer Have High Out-of-Pocket Costs

Patients with cancer who have Medicare health insurance spend a high percentage of their annual income on out-of-pocket medical costs, a recent study found. 
BY ALLIE CASEY
PUBLISHED: JANUARY 04, 2017
Patients with cancer who have Medicare and no supplemental insurance – many who are elderly and disabled – spend, on average, about a quarter of their income on out-of-pocket medical costs. Some patients reported spending as high as 63 percent of their annual income to pay medical bills, according to a recent study conducted by the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Kimmel Cancer Center.
 
The survey-based study, “Out-of-pocket spending and financial burden among Medicare beneficiaries with cancer,” looked at 18,000 Medicare beneficiaries interviewed between 2002 and 2012 for the National Institute on Aging’s Health and Retirement Survey. During the study period, 1409 of the patients were diagnosed with cancer.

Of the patients studied, 15 percent had no supplemental insurance beyond their Medicare coverage; 50 percent had the Medigap plan or still had employer or retiree benefits; 20 percent participated in a Medicare HMO; 9 percent were eligible for Medicaid and 6 percent received benefits from the Veterans Administration (VA).

This study found that annual out-of-pocket costs for patients with Medicare ranged from $2,116 to $8,115 among patients with no supplemental insurance (not including the costs of paying for health insurance itself), depending on which, if any, supplemental health insurance the patient had.

Those with Medicaid in addition to Medicare saw an average annual out-of-pocket cost with a new diagnosis of cancer of $2,116. For those with benefits from the VA, the annual cost was $2,367. With employer-sponsored plans, costs jumped to $5,492. Patients with a Medigap plan had annual out-of-pocket costs of approximately $5,670. With Medicare HMOs, it was $5,976, and for those patients with no supplemental insurance of any kind the annual out-of-pocket costs with a new cancer diagnosis averaged at $8,115.

For those patients without supplemental insurance, the average costs were one-quarter of their annual income. For 10 percent of those patients, the costs were at least 63 percent of their annual income.

“Cancer costs are high,” said Amol K. Narang, M.D., coauthor of the study, “and a significant segment of our seniors who don’t have adequate insurance coverage can be hit hard by this.” Coauthor Lauren Hersch Nicholas, M.D., concurred: “The health shock can be followed by financial toxicity. In many cases, doctors can bring you back to health, but it can be tremendously expensive and a lot of treatments are given without a discussion of the costs or the financial consequences.”

The study also found that hospitalization was a major driver of out-of-pocket costs. The copay for each hospital visit is $1,000. For patients with cancer, inpatient hospitalization accounted for between 12 percent and 46 percent of out-of-pocket spending, depending upon whether or what type of supplemental insurance a patient had.



Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
x-button
Special Feature
Share Your Art
Related Articles
Complementary Therapies for Cancer Treatment Are Coming of Age
Nonmedical treatments offering physical and psychosocial relief are gaining respect in the medical community.
Chemo Brain Barb
Two-time cancer survivor shares the frustrations of struggling with chemo brain. And yes, it's real.
Friendships of Cancer
If cancer gave us one gift in life, it was the friendships formed along the way.
Related Videos
Preserving Eyebrows During Chemotherapy Treatment
Renata Marie Vestevich, founder and developer of Essential Eyebrow Solution (EES), discusses how this topical solution may be able to help patients keep their eyebrow hair while undergoing chemotherapy.
Does Age Affect Cancer Genomics?
Garrett Frampton, associate director of Cancer Genomics at Foundation Medicine, discusses recent research about genetic mutations that are more common in certain age groups.  
Facing Advanced Cancer's Struggles With CALM
Gary Rodin, M.D., head of the Department of Supportive Care at Princess Margaret Cancer Centre, in Toronto, Canada, discusses CALM, an intervention designed to help patients with advanced-stage cancer cope and talk about their concerns.
x
//For side ad protocol